6397 RESULTS
Sort By:
The Human Connectome Project: Deciphering the Brain’s Wiring The Many Faces of LRRK2 New Strategies for Early Diagnosis of AD Animal Model Redux: New Lessons From Old Transgenics? SfN: Glial-Neuronal Signaling and AD Pathology SfN: Epigenetic Changes in A
Notes from International AD/PD Conference 2003 in Seville International Conference on Alzheimer's & Parkinson's Diseases 2003
Sorrento: Immunotherapy Update Hot Off Lectern of AD/PD Conference Sorrento: Scientists Stop Clubbing, Start Tweaking, γ-Secretase Sorrento Secretase News: Baiting β, Awakening α Sorrento: More Fun, Less Amyloid for Transgenic Mice Sorrento: They’ve Just
Salzburg Overview: 8th International Conference Draws Record Number Salzburg: New Proteins Redefine Frontotemporal Dementias Salzburg: Getting to Know Progranulin, the New Heavy Salzburg: Protein Trio Offers Handle on Elusive ERAD Salzburg: The Pony in Th
Barcelona: 10th AD/PD Conference Hosts a Shaken, Restive Field Barcelona: Straight Talk From a Regulator on Trials in Parkinson’s Barcelona: Taking Parkinson’s Research From Movement to Mind Barcelona: What Lies Beyond Genomewide Association Studies? Barc
Tau, α-Synuclein Spread: Crazy Stuff—How Might It Work? Like Star Born of Supernova, Plaque Born of Exploded Neuron? Can Dousing PyroGlu-Aβ Treat Alzheimer’s Disease? Field Ramps Up "Mini" Mouse MRI LRRK Watchers’ Eyes Turn to Inflammation, Auto
HAI Chicago: PIB in Healthy People HAI Chicago: Can PIB Predict Cognitive Decline? HAI Chicago: PIB and Aβ Show Regional Nuances and Sleep-Wake Rhythm HAI Chicago: Not Just PIB—Other PET Tracers in Clinical Pipeline Human Amyloid Imaging 2008
HAI Seattle: Does Brain Amyloid Correlate With Sagging Metabolism? HAI Seattle: Aβ May Disrupt Brain Function in Normal Seniors HAI Seattle: Not Just Amyloid, Not Just PIB HAI Seattle: Biomarkers Closing in on AD Pathological Sequence? Human Amyloid Imagi
Toronto: Human Amyloid Imaging Conference Showcases a Maturing Field Toronto: Ah, The Devil in the Details Toronto: Last Gift to Science—Hospice Patients Validate Amyloid Ligand Toronto: Sister 18F Ligands Jostle for Primacy Toronto: HAI Amyloid Imaging C
Miami: Women Rock at Human Amyloid Imaging Meeting Miami: Amyloid in the Aging Brain—What Does It Mean? Miami: Multimodal Imaging, New Way to Test Amyloid Hypothesis Miami: Astrocytes, Antidepressants, Microbleeds, and More Miami: Updates on J-ADNI, 18F T
News Focus: 2012 Human Amyloid Imaging Conference Miami: Amyloid PET in the Clinic: What Are the Issues? Miami: Scan and Tell? Amyloid Imaging Confronts Disclosure Dilemma Miami: Can the Naked Eye Tell When a Scan Is Positive? Miami: When Does Amyloid Dep
Solanezumab Selected for Alzheimer’s A4 Prevention Trial HAI—Spotlight on Tau Tracers at Human Amyloid Imaging Meeting HAI—Amyloid Imaging in the Clinic: New Guidelines and Data HAI—Sharper Curves: Revamping a Biomarker Staging Model HAI—Standardizing Amy
Boston: Clinical Trial Results for Dimebon Unveiled Boston: Resting State MRI Shows Loss of Network Connectivity Early in AD American Academy of Neurology: 2007 Annual Meeting
Las Vegas: New Partner, New Game Plan for Lou Ruvo Brain Institute Las Vegas: AD, Risk, ApoE—Tomm40 No Tomfoolery Las Vegas: Prevention Prominent at CTAD Las Vegas: 2020 Vision—AD Prevention in 11 Years? Clinical Trials on Alzheimer’s Disease 2009
A deletion in chromosome 22 points to new genetic risk factors for Parkinson's disease.
No filters selected
